Clinical Trial Update: A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day [Phase 2]

View source ↗

Summary

Phase 2 study comparing weekly somapacitan to daily Norditropin in children born small for gestational age; results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature
• Small For Gestational Age

Drugs mentioned

• Norditropin (somatropin)
• Somapacitan (somapacitan)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Short Stature Children Born Small for Gestational Age (SGA) | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-06-20